Harrington Investments INC acquired a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 22,320 shares of the pharmacy operator’s stock, valued at approximately $1,724,000. Walgreens Boots Alliance comprises 1.6% of Harrington Investments INC’s portfolio, making the stock its 27th biggest position.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Franklin Resources Inc. lifted its holdings in shares of Walgreens Boots Alliance by 24.7% in the 2nd quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock valued at $1,448,939,000 after buying an additional 3,662,302 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in Walgreens Boots Alliance by 471.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares during the last quarter. Vanguard Group Inc. raised its holdings in Walgreens Boots Alliance by 2.8% during the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after purchasing an additional 1,926,108 shares during the last quarter. Wellington Management Group LLP raised its holdings in Walgreens Boots Alliance by 5.9% during the first quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after purchasing an additional 1,824,300 shares during the last quarter. Finally, Glenview Capital Management LLC acquired a new position in Walgreens Boots Alliance during the second quarter worth $136,875,000. Institutional investors and hedge funds own 61.41% of the company’s stock.
Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.55 on Monday. The firm has a market capitalization of $70,859.95, a P/E ratio of 14.03, a price-to-earnings-growth ratio of 1.28 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the prior year, the firm earned $1.07 EPS. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. equities analysts predict that Walgreens Boots Alliance Inc will post 5.54 EPS for the current fiscal year.
Walgreens Boots Alliance announced that its board has initiated a share buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Walgreens Boots Alliance’s payout ratio is currently 42.33%.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director John Anthony Lederer purchased 20,000 shares of the firm’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 14.80% of the company’s stock.
Several equities analysts have weighed in on WBA shares. UBS reissued a “buy” rating and set a $96.00 price target (down previously from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. Loop Capital started coverage on Walgreens Boots Alliance in a research report on Thursday, August 24th. They issued a “buy” rating and a $95.00 price objective for the company. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Jefferies Group reaffirmed a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price objective on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $86.47.
ILLEGAL ACTIVITY NOTICE: “Harrington Investments INC Invests $1.72 Million in Walgreens Boots Alliance Inc (WBA)” was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://transcriptdaily.com/2017/12/11/harrington-investments-inc-invests-1-72-million-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.